Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MNC Pharma Stocks 

Here are the latest stock price details of India's top MNC Pharma stocks. For more detailed updates, read our MNC Pharma sector report and check the latest MNC Pharma sector results.

2020 Special Report : 7 Stocks to Ride the Coming Rebirth of India Rally. Full Details Here...

» Result Scoreboard | Best Performing Stocks | Refresh
SCRIP BSE PRICE (Rs) NSE PRICE (Rs) CHART MORE INFO
ABBOTT INDIA 14,663.00 -0.72% 14,650.95 -0.91%
 More Info 
GSK PHARMA 1,315.90 -1.25% 1,317.05 -1.41%
 More Info 
NIFTY 50 Not Listed 12,045.80 -0.56%
 More Info 
NOVARTIS 622.95 -2.83% Not Listed
 More Info 
PFIZER 4,029.00 -3.81% 4,032.75 -3.83%
 More Info 
PROCTER & GAMBLE HEALTH 4,205.90 -2.00% 4,205.00 -2.15%
 More Info 
S&P BSE SENSEX 41,055.69 -0.49% Not Listed
 More Info 
SANOFI INDIA 7,229.85 -1.87% 7,225.50 -1.93%
 More Info 

BSE prices: February 17, 2020  (Close)    NSE prices: February 17, 2020  (Close)

MNC Pharma Stocks Update

The NIFTY PHARMA Index was at 8,205.1 (down 1.5%). The index is down 20.4% over the last 30 days. And over the last 1 year, it has lost 12.7%.

Within the MNC Pharma sector, PFIZER (down 3.8%) and NOVARTIS (down 2.8%) were among the top losers.

Meanwhile, the benchmark NIFTY 50 was at 12,045.8 (down 0.6%).




Today's Market

Moody's GDP Growth Forecast, Slump in Equity Mutual Fund Inflows, and Top Cues in Focus Today(Pre-Open)

India share markets witnessed selling pressure during closing hours yesterday and ended on a negative note.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

More Views on News

Most Popular

Buy this 'Crorepati Stock' and You Could End Up Stinking Rich (Profit Hunter)

Feb 5, 2020

I'm talking about an individual small cap stock that could go up so many times that they make their investors stinking rich in the process. You definitely want to know more...

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years) (Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Will Your Trade Go Up or Down Today? (Fast Profits Daily)

Feb 5, 2020

How you can find out which way your trade is likely to move on any given trading day.

Will Algo Traders Take Away All Your Profits? (Fast Profits Daily)

Feb 11, 2020

How to fight back against algo trading systems.

No Change in My Long-Term View on the Rebirth of India Stocks (The 5 Minute Wrapup)

Feb 6, 2020

Why the recent post budget volatility has not affected my bullish view on the Rebirth of India stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Feb 17, 2020 (Close)

COMPARE COMPANY

MARKET STATS